Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Staying in the back seat to Keytruda, Bristol Myers reports another pivotal setback in urothelial cancer
4 years ago
R&D
Seeking a come-from-behind win, Eli Lilly lands big approval for next-gen diabetes drug
4 years ago
FDA+
Roche chairman Christoph Franz offers glint of hope after tiragolumab fail — report
4 years ago
J&J’s ‘Texas two-step’ talc bankruptcy case heads back to appeals court
4 years ago
Law
Striking murals in US cities highlight Horizon and Arthritis Foundation collab for gout awareness
4 years ago
Marketing
UK generics maker shutters, eliminating 1,000 jobs
4 years ago
Manufacturing
Israel sues Teva over blockbuster MS drug, seeking $100M in royalty pay — report
4 years ago
Law
Roche ends a bad, no good, plain lousy week with a $0 co-pay copycat stalking one of its blockbusters
4 years ago
Bristol Myers Squibb strikes deal to sell NY site to South Korean conglomerate — but it's keeping quiet on the details
4 years ago
Deals
Manufacturing
BioFrontera bows bold imagery websites amid Q1 sales gains in dermatology
4 years ago
Marketing
AbbVie unveils latest round of immunology scholarships for patients with chronic disease
4 years ago
After ramping up its vaccine production in South Africa, Aspen yet to receive a single order
4 years ago
Manufacturing
Roche's TIGIT fallout causes GSK and iTeos to re-think their own I/O candidate
4 years ago
R&D
Regeneron didn't want to 'bid against itself' in Checkmate deal as five global pharmas declined to counteroffer
4 years ago
Deals
CSL's $11.7B buyout hits antitrust delay — is it a sign of what's to come?
4 years ago
Teva, Allergan open to settling 3500+ lawsuits for more than $5B as negotiations continue — report
4 years ago
Global license program to receive Covid-19 support from the NIH
4 years ago
Coronavirus
Boy bands and psoriatic arthritis? NSYNC’s Lance Bass creates new dance for Amgen about early signs
4 years ago
Marketing
PCI further expands into New England with fill-finish upgrade in New Hampshire
4 years ago
Manufacturing
‘Say no more’ to yeast infections: Scynexis rolls out new Brexafemme marketing — and rallying cry
4 years ago
Marketing
Indian manufacturer hit with Form 483 — again
4 years ago
FDA+
Q&A: Through robotics, Fred Parietti and team look to fix cell therapy's future
4 years ago
Manufacturing
Bristol Myers builds the case for psoriasis hopeful as it waits in regulatory limbo
4 years ago
R&D
A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers
4 years ago
Deals
R&D
First page
Previous page
200
201
202
203
204
205
206
Next page
Last page